U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry UNKNOWN
Molecular Formula C10H7Cl2N3O2
Molecular Weight 272.087
Optical Activity ( + / - )
Defined Stereocenters 0 / 1
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of 3-HYDROXY ANAGRELIDE

SMILES

OC1N2CC3=C(Cl)C(Cl)=CC=C3NC2=NC1=O

InChI

InChIKey=KAXTUTDKZVOONF-UHFFFAOYSA-N
InChI=1S/C10H7Cl2N3O2/c11-5-1-2-6-4(7(5)12)3-15-9(17)8(16)14-10(15)13-6/h1-2,9,17H,3H2,(H,13,14,16)

HIDE SMILES / InChI

Molecular Formula C10H7Cl2N3O2
Molecular Weight 272.087
Charge 0
Count
Stereochemistry RACEMIC
Additional Stereochemistry No
Defined Stereocenters 0 / 1
E/Z Centers 0
Optical Activity ( + / - )

Approval Year

Substance Class Chemical
Created
by admin
on Sat Dec 16 14:54:05 UTC 2023
Edited
by admin
on Sat Dec 16 14:54:05 UTC 2023
Record UNII
PIN0NPZ24B
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
3-HYDROXY ANAGRELIDE
Common Name English
6,7-Dichloro-1,5-dihydro-3-hydroxyimidazo[2,1-b]quinazolin-2(3H)-one
Systematic Name English
BCH-24426
Common Name English
BCH24426
Common Name English
Code System Code Type Description
PUBCHEM
135424310
Created by admin on Sat Dec 16 14:54:06 UTC 2023 , Edited by admin on Sat Dec 16 14:54:06 UTC 2023
PRIMARY
FDA UNII
PIN0NPZ24B
Created by admin on Sat Dec 16 14:54:06 UTC 2023 , Edited by admin on Sat Dec 16 14:54:06 UTC 2023
PRIMARY
CAS
733043-41-9
Created by admin on Sat Dec 16 14:54:06 UTC 2023 , Edited by admin on Sat Dec 16 14:54:06 UTC 2023
PRIMARY
Related Record Type Details
TARGET -> INHIBITOR
May be responsible for Cardiac related adverse events.
IC50
Related Record Type Details
PARENT -> METABOLITE ACTIVE
Name Property Type Amount Referenced Substance Defining Parameters References
Volume of Distribution PHARMACOKINETIC
Biological Half-life PHARMACOKINETIC